Cellyan Biotechnology Co., Ltd SEC filings HKPD

Cellyan Biotechnology Co., Ltd has 67 filings in SEC EDGAR's recent list, going back to Mar 29, 2024. Its latest annual report, Form 20-F, was filed on Aug 7, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.

Form Description Filed Period
3 Initial insider ownership Jun 12, 2026 Mar 18, 2026
3 Initial insider ownership Jun 10, 2026 Mar 18, 2026
3 Initial insider ownership Jun 9, 2026 Mar 18, 2026
3 Initial insider ownership Jun 8, 2026 Mar 18, 2026
3 Initial insider ownership Jun 8, 2026 Mar 18, 2026
3 Initial insider ownership Jun 8, 2026 Mar 18, 2026
3 Initial insider ownership Jun 8, 2026 Mar 18, 2026
SCHEDULE 13D Ownership over 5% (active) Nov 12, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 5, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Jun 3, 2025 —

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
HKPD (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Cayman Islands
Headquarters
Kowloon
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
2007702
Former names
Hong Kong Pharma Digital Technology Holdings Ltd (until Dec 17, 2025)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.